Egypt Hypertension Study

Trial Identifier:	D1843R00249
Sponsor:	AstraZeneca
NCTID::	NCT02604771
Start Date:	April 2016
Primary Completion Date:	February 2018
Study Completion Date:	February 2018
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Egypt, Cairo	Egypt, Cairo, Egypt

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.